
Imrecoxib
CAS No. 395683-14-4
Imrecoxib ( BAP-909 )
产品货号. M24356 CAS No. 395683-14-4
Imrecoxib 是一种新型选择性环氧合酶 2 (COX-2) 抑制剂 (IC50: 18 nM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥243 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Imrecoxib
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Imrecoxib 是一种新型选择性环氧合酶 2 (COX-2) 抑制剂 (IC50: 18 nM)。
-
产品描述Imrecoxib is a novel and selective cyclooxygenase 2 (COX-2) inhibitor (IC50: 18 nM). It also inhibits COX1- activity (IC50: 115 nM). Imrecoxib has an anti-inflammatory effect.
-
体外实验Imrecoxib (BAP-909) (0.1-10 μM; 24 hours) decreases COX-2 mRNA level induced by PMA+LPS at a dose dependent manner in U937 cells. RT-PCRCell Line:U937 cells Concentration:0.1 μM; 1 μM; 10 μM Incubation Time:24 hours Result:Decreased COX-2 mRNA level.
-
体内实验Imrecoxib (BAP-909) (gastrointestinal administration; 5-20 mg/kg; 1 hour before carrageenan injection) inhibits carrageenan-induced acute inflammation, and the inhibitory effect is maximal at 4 hours.Imrecoxib (BAP-909) (gastrointestinal administration; 5-20 mg/kg; started on day 7; 26 days) diminishes the secondary paw swelling and inhibits heat-inactivated BCG induced-inflammtory polyarthritis. Animal Model:Rat carrageenan-induced edema modelDosage:5 mg/kg, 10 mg/kg, 20 mg/kg Administration:Gastrointestinal administration; 5-20 mg/kg; 1 hour before carrageenan injection Result:Inhibited the edema response with different doses.Animal Model:Rat adjuvant-induced arthritis (AIA) model Dosage:5 mg/kg, 10 mg/kg, 20 mg/kg Administration:Gastrointestinal administration; 5-20 mg/kg; started on day 7; 26 days Result:Inhibited adjuvant-induced chronic inflammation at the doses of 10 and 20 mg/kg.
-
同义词BAP-909
-
通路Chromatin/Epigenetic
-
靶点COX
-
受体COX-1|COX-2
-
研究领域——
-
适应症——
化学信息
-
CAS Number395683-14-4
-
分子量369.48
-
分子式C21H23NO3S
-
纯度>98% (HPLC)
-
溶解度DMSO: 90 mg/mL (243.59 mM; Need ultrasonic)
-
SMILESO=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Chen XH, et al. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin. 2004 Jul;25(7):927-31.
产品手册




关联产品
-
Indomethacin sodium ...
Indomethacin (Indometacin) sodium hydrateis 是一种有效的口服活性 COX1/2抑制剂,COX-1 和 COX-2 的IC50 值分别为 18 nM 和 26 nM。Indomethacin sodium hydrateis 具有抗癌和抗感染活性。Indomethacin sodium hydrateis 可用于癌症、炎症和病毒感染的研究。
-
Isoxicam
异昔康是一种新型长效非甾体抗炎药,用于治疗关节炎。
-
(+)-Catechin pentaac...
(+)-Catechin pentaacetate 是生产 (+) catechin (HY-N0898 ) 的前体。(+) catechin 是一种有用的天然除草剂和抗菌剂。(+) catechin 抑制环加氧酶-1 (COX-1), IC50 为 1.4 μM。